Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRME
PRME
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRME News
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
6d ago
PRnewswire
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
6d ago
Newsfilter
Prime Medicine Focuses on Liver Franchise with $191.4M Cash Runway
Mar 08 2026
Yahoo Finance
Prime Medicine Reports FY 2023 Financial Results
Mar 03 2026
seekingalpha
Prime Medicine Reports Q4 2025 Results and Future Milestones
Mar 03 2026
seekingalpha
Prime Medicine to Participate in Three Major Conferences
Feb 25 2026
Yahoo Finance
Avant Technologies Drives Gene Therapy Market to $36.55 Billion by 2032
Jan 02 2026
Newsfilter
Avant Technologies Drives Gene Therapy Market to $36.55 Billion by 2032
Jan 02 2026
PRnewswire
Prime Drink Group Closes $450,000 Non-Brokered Private Placement
Jan 01 2026
Globenewswire
PrimeDrink Group Plans Non-Brokered Private Placement to Raise Up to $5 Million
Dec 18 2025
Globenewswire
Prime Medicine Publishes Phase 1/2 Data for PM359, Demonstrating Significant Efficacy
Dec 07 2025
Globenewswire
Prime Medicine Publishes Phase 1/2 Data for PM359, Demonstrating Significant Efficacy
Dec 07 2025
Newsfilter
Prime Medicine to Showcase at Jefferies Global Healthcare Conference
Nov 11 2025
Newsfilter
Chardan Capital Keeps Buy Rating on Prime Medicine, Reduces Price Target to $9
Nov 10 2025
Benzinga
Prime Medicine Announces Financial Results for Q3 2025 and Shares Business Developments
Nov 07 2025
Newsfilter
My Leading Biotech Stock Selections and Investment Approach for the Coming 3-10 Years
Sep 18 2025
Benzinga
Show More News
